Systemic Immuno-metabolic alterations in chronic obstructive pulmonary disease (COPD)

Area of Science:

• Immunology
• Metabolic pathways
• Cellular metabolism

Background:

• Immune cell function is intrinsically linked to intracellular metabolism.
• Long-term tobacco smoke exposure impacts immune cell metabolic states.
• Characterizing metabolic changes in smokers and COPD patients is crucial.

Purpose of the Study:

• To investigate the metabolic state of peripheral blood mononuclear cells (PBMCs) in healthy non-smokers, healthy smokers, and COPD subjects.
• To correlate metabolic function with lung function parameters.
• To explore the in vitro effects of cigarette smoke on immune cell metabolism and function.

Main Methods:

• Isolation and culture of PBMCs from different subject groups.
• Measurement of mitochondrial respiration (oxygen consumption rate) and glycolysis (extracellular acidification rate).
• Analysis of inflammatory cytokine levels and in vitro assessment of cell viability, metabolism, and phagocytosis after cigarette smoke condensate exposure.

Main Results:

• COPD subjects showed significantly reduced glucose utilization (ECAR) and mitochondrial respiration (OCR) compared to healthy non-smokers.
• A positive correlation was observed between fatty acid metabolism (palmitate OCR) in PBMCs and lung function (FEV1, FVC) in healthy smokers.
• Exposure to cigarette smoke condensate in vitro altered cellular metabolism and reduced phagocytic capacity.

Conclusions:

• Immune cell metabolic dysfunction provides a basis for the inflammatory response in COPD.
• Targeting metabolic pathways may offer a novel therapeutic strategy for managing COPD and related inflammatory conditions.
• Understanding these metabolic adaptations is key to developing interventions to delay disease progression.